A similar effect was noted in the protein abundance of ADIPOQ in the uterus of all experimental groups, except PCOS rats treated with VD3, where the ADIPORQ was at the same level as in the control rats (Figure 7B, p < 0.05). Here, ADIPOQ is linked to polycystic ovary syndrome.